Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Indivumed
AddedFeb 17, 2024
UpdatedJun 18, 2026
Indivumed

Indivumed

Indivumed: A global biopharma partner specializing in individualized cancer therapy and biologic sample analysis.

HQ
Georgia, US
Founded
2002
Overview
Compare
Fundraising
Employees
Website

Indivumed, founded in Hamburg, Germany in 2002, is dedicated to the individualization of cancer therapy through the generation, characterization, and analysis of biological samples from human cancer patients. The company offers screening-ready novel target packages for precision oncology, aiming to advance the discovery and development of novel drugs. Indivumed collaborates with leading cancer clinics in Europe, the US, and Asia, and partners with over 100 biopharma industry entities globally.

Notable figures associated with Indivumed include its founder, Hartmut Juhl, a prominent figure in cancer research. The company has achieved significant milestones, such as establishing partnerships with more than 50 oncology practices in Germany and gaining a global reputation for its contributions to cancer therapy. Indivumed's impact is evident in its commitment to creating precise therapeutic treatments that offer high probabilities of successful therapeutic development, significantly advancing the field of oncology.

Indivumed - Similar Companies

Imvaq Therapeutics logo

Imvaq Therapeutics

Helomics logo

Helomics

INmune Bio logo

INmune Bio

inmunebio.com

Immunome logo

Immunome

Foundation Medicine logo

Foundation Medicine

Personalis logo

Personalis

personalis.com

Intellimedix logo

Intellimedix

Genomind logo

Genomind

genomind.com

Imidomics logo

Imidomics

imidomics.com

Ultivue logo

Ultivue

ultivue.com

OncoPrecision logo

OncoPrecision

oncoprecision.bio

HI-Bio logo

HI-Bio

hibio.com

Umoja Biopharma logo

Umoja Biopharma

Caris Life Sciences logo

Caris Life Sciences

carisls.com

Precision IBD logo

Precision IBD

Indivumed - Quick Facts

Who are Indivumed's competitors?

Companies similar to Indivumed include Imvaq Therapeutics, Helomics, INmune Bio and Immunome.

When was Indivumed founded?

Indivumed was founded in 2002.

Where is Indivumed's headquarters located?

Indivumed's headquarters is located in Georgia, US.

When was Indivumed's last funding round?

Indivumed's most recent funding round was for $40M (USD) in January 2018.

How much has Indivumed raised to-date?

As of Jan 9, 2018, Indivumed has raised a total of $40M (USD).

How many employees does Indivumed have?

Indivumed has 175 employees as of Feb 4, 2024.

Indivumed - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Customer
  • Enterprise
Main Product
  • Biologic Sample Analysis
Tags
  • Biotech
  • Consulting
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 24 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research